SCHEMBL3319244

SCHEMBL3319244

CC(C)([CH]C(=O)N1CCN(C(=O)c2cccnc2Cl)CC1)C(N)=O

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.61
CYP2C19 P33261 1/20 0.48
LMNA P02545 4/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PIK3CG P48736 1/20 0.39
GAA P10253 1/20 0.39
SLC6A7 Q99884 1/20 0.39
PARP1 P09874 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3321803 0.87 POLB (0.45) POLBCYP2C19LMNAALDH1A1KDM4E
SCHEMBL3319292 0.80 L3MBTL1 (0.62) ALDH1A1SMN1; SMN2GAAL3MBTL1
SCHEMBL3319245 0.79 POLB (0.61) POLBCYP2C19LMNAMAPTALDH1A1
SCHEMBL3764825 0.77 POLB (0.61) POLBCYP2C19LMNAMAPTALDH1A1
SCHEMBL3320701 0.76 KDM4E (0.48) POLBCYP2C19LMNAMAPTALDH1A1
SCHEMBL5643040 0.76 MAPK1 (0.55) POLBLMNAMAPTALDH1A1KMT2A
SCHEMBL12832991 0.76 POLB (1.00) POLBCYP2C19LMNAMAPTKMT2A
SCHEMBL1976542 0.76 POLB (0.65) POLBCYP2C19LMNAMAPTALDH1A1
SCHEMBL1865263 0.74 POLB (0.63) POLBCYP2C19LMNAMAPTALDH1A1
SCHEMBL1863115 0.74 POLB (0.63) POLBCYP2C19LMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100125075-A1 Antibacterial Agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2010-05-20 US disclosed
US-7186719-B2 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS (GB) 2007-03-06 US disclosed
US-20050065095-A1 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2005-03-24 US disclosed
US-6846825-B1 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2005-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065095-A1 Antibacterial agents NQO2, DAO, Q6ZSR9 POLB 771/4885CYP2C19 939/4885LMNA 2462/4885
US-20100125075-A1 Antibacterial Agents NQO2, DAO, Q6ZSR9 POLB 752/4885CYP2C19 1050/4885LMNA 2435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.